Event Details

When

Thursday, November 15, 2018
8:00am to 4:00pm EST
Add to Calendar

Where

Rutgers University Ernest Mario School of Pharmacy
160 Frelinghuysen Rd.
Piscataway, NJ 08854

 

Event Homepage

2018 Regional Academic Drug Discovery Conference
 

 New Jersey Academic Drug Discovery Consortium
 

    

Parking

Lot 58 and Lot 58a have been reserved for this event. Attendees who do not have a Rutgers parking permit are required to register your vehicle here. To the right is a map depicting the parking lots and their relation to the event (click to enlarge).

Agenda

Morning  

8:00am

Registration

Poster Session, Networking, Coffee & Refreshments

9:00am

Rutgers Welcome

Christopher Molloy, Ph.D., R.Ph. – Interim Chancellor, Rutgers University—New Brunswick

 

Ernest Mario School of Pharmacy’s Welcome

Joseph A. Barone, PharmD, FCCP Dean and Professor II, Ernest Mario School of Pharmacy, Rutgers University

9:20am

Keynote: Translational Research, a Perspective from NIH NCATS

Philip E. Sanderson, Ph.D. – Project Leader and Manager, Therapeutics for Rare and Neglected Diseases, National Institutes of Health

10:00am

Academic Industry Partnerships, a Perspective from Celgene

Michael Cox – Executive Director, BD & Global Alliances, Celgene Corporation

10:40am

Coffee Break

Poster Session, Networking

11:10am

Small Molecule Drug Discovery: Transitioning from Industry to Academia

Robert DeVita, Ph.D. – Professor, Icahn School of Medicine & Director, Medicinal Chemistry, Drug Discovery Institute, Mount Sinai

11:55am

Lunch

Poster Session, Networking

Afternoon

 

1:15pm

Building an Academic Drug Discovery Ecosystem

S. David Kimball, Ph.D. – Interim Senior Vice President, Research and Economic Development (ORED), Rutgers University

1:30pm

Panel Discussion

Vincent Smeraglia  Executive Director, Strategic Alliances, ORED, Rutgers University

Kirsten Leute, MBA  Senior Vice President, University Relations, Osage University Partners

John Anthes, Ph.D.  Director, Thomas O. Daniel Research Incubator and Collaboration Center, Celgene Corporation

Chari Smith, Ph.D. – Princeton University
Nishta Rao, Ph.D. – Director, Princeton Innovation Center BioLabs

2:00pm

Development of an EBNA1 Inhibitor for the Treatment of EBV-Positive Cancer

Troy Messick, Ph.D. Senior Staff Scientist, Wistar Institute

2:45pm

Nanomedicine: From High Tech to Global Health

Robert K. Prud'homme, Ph.D. – Professor, Chemical and Biological Engineering, Princeton University

3:15pm

Coffee Break

Poster Session, Networking

3:45pm

From Bench to Bedside, the Development of Leukothera® for White Blood Disease

Scott Kachlany, Ph.D.  Associate Professor, Oral Biology, School of Dental Medicine, Rutgers University

4:15pm

ILSE: Accelerating drug development

Robert McLaughlin, Ph.D.  Institute for Life Science Entrepreneurship (ILSE)

4:45pm

Parasitic Protein Kinases as Potential Drug Targets: The Case for Brugia Malayi and Plasmodium Falciparum

John Siekerka, Ph.D. – Director, Margaret and Herman Sokol Institute for Pharmaceutical Life Sciences & Sokol Professor of Medicinal Chemistry, Montclair University

5:15pm

End

Questions and Sponsorship Opportunities

Vince Smeraglia, vincent.smeraglia@rutgers.edu, 732-956-6123

Poster Presentations

For poster presentation questions (poster size: landscape 36 in x 24 in), email Troy Messick (tmessick@wistar.org).

 

Thank You to Our Sponsors

 


 

Additional Thanks (pdf)